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Increased sensory input from maternal care attenuates neuroendocrine and behavioral responses to stress long term and results in a
lifelong phenotype of resilience to depression and improved cognitive function. Whereas the mechanisms of this clinically important
effect remain unclear, the early, persistent suppression of the expression of the stress neurohormone corticotropin-releasing hormone
(CRH) in hypothalamic neurons has been implicated as a key aspect of this experience-induced neuroplasticity. Here, we tested whether
the innervation of hypothalamic CRH neurons of rat pups that received augmented maternal care was altered in a manner that might
promote the suppressionofCRHexpressionandstudied the cellularmechanismsunderlying this suppression.We found that thenumber
of excitatory synapses and the frequency ofminiature excitatory synaptic currents ontoCRHneuronswere reduced in “care-augmented”
rats compared with controls, as were the levels of the glutamate vesicular transporter vGlut2. In contrast, analogous parameters of
inhibitory synapses were unchanged. Levels of the transcriptional repressor neuron-restrictive silencer factor (NRSF), which negatively
regulates Crh gene transcription, were markedly elevated in care-augmented rats, and chromatin immunoprecipitation demonstrated
that this repressor was bound to a cognate element (neuron-restrictive silencing element) on the Crh gene. Whereas the reduced excita-
tory innervationofCRH-expressingneuronsdissipatedby adulthood, increasedNRSF levels and repressionofCRHexpressionpersisted,
suggesting that augmented early-life experience reprograms Crh gene expression via mechanisms involving transcriptional repression
by NRSF.
Introduction
Early-life experience induces persistent neuroplasticity of the
neuroendocrine stress system, with implications for emotional
and cognitive function (Levine, 1967). This plasticity, character-
ized by reduced stress responses (Plotsky and Meaney, 1993;
Avishai-Eliner et al., 2001a), increased resilience to depressive-
like behavior (Meaney et al., 1991), and improved learning and
memory (Liu et al., 2000; Fenoglio et al., 2005), can be induced by
brief daily separation of rat pups from the dam during the first
weeks of life, which promotes maternal-derived sensory input
(Liu et al., 1997; Fenoglio et al., 2006).
At a molecular level, adult rats experiencing augmented ma-
ternal sensory input have altered basal expression of key neuronal
genes involved in regulating neuroendocrine and behavioral
stress responses (Joe¨ls and Baram, 2009). These include reduced
expression of corticotropin-releasing hormone (CRH) in hypo-
thalamic paraventricular nucleus neurons, attenuated hormonal
stress response, and increased expression of glucocorticoid re-
ceptor in hippocampal neurons (Plotsky and Meaney, 1993; Liu
et al., 1997; Fenoglio et al., 2005). Experience-induced reduction
in CRH expression was apparent already by postnatal day 9 (P9),
preceding both the diminished hormonal stress responses and
the increased hippocampal glucocorticoid receptor (GR) expres-
sion (Avishai-Eliner et al., 2001a). These observations, together
with the fact that the “experience-augmented” phenotype could
be reproduced by reducing interactions of CRH with its receptor
during development (Fenoglio et al., 2005), suggested that re-
duced CRH expression was an early, key element of the process
leading from enhanced maternal sensory input to the enduring
phenotype described above.
What is the nature of signals, derived from maternal sensory
experience, that reaches CRH neurons? The CRH neuron is a
component of a neuronal network activated by maternal care
(Fenoglio et al., 2006). Therefore, it is reasonable to assume that
augmented early-life experience alters excitatory and/or inhibi-
tory synaptic input onto CRHneurons and that this alteration, in
turn, triggersmolecularmachinery that enduringly reduces CRH
expression.
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Synaptic innervation of individual (including hypothalamic)
neurons has recently emerged as dynamic and modulated by ex-
perience (Verkuyl et al., 2004;Horvath, 2005). For CRHneurons,
the majority of input is mediated by GABAergic and glutamater-
gic synapses (Boudaba et al., 1997; Miklos and Kovacs, 2002;
Ziegler et al., 2005), via GABAA (Cullinan, 2000) and glutamate
receptors (Aubry et al., 1996; Kiss et al., 1996; Di et al., 2003).
GABA and glutamate are transported into presynaptic vesicles by
vesicular transporters, vGat (McIntire et al., 1997) and vGlut
(Herzog et al., 2001), respectively, so that these transporters
provide specific markers for inhibitory and excitatory afferent
synaptic contacts onto CRHneurons. Here, we combined quan-
tification of these markers, usingWestern blot, quantitative con-
focal and electron microscopy, and electrophysiology, to
examine the effects of early-life experience on excitatory and in-
hibitory synapses abutting CRH neurons. We then examined the
molecular machinery underlying the persistent suppression of
CRH expression, testing whether augmented early-life experi-
ence increased expression of the repressor neuron-restrictive si-
lencer factor (NRSF) (Mori et al., 1992; Palm et al., 1998),
because of the presence of a functional binding site for this re-
pressor within the Crh gene (Seth and Majzoub, 2001).
Materials andMethods
Animals. Thirty-two timed-pregnant Sprague Dawley rats were housed
in an uncrowded, quiet animal facility room on a 12 h light/dark cycle
and were provided with food and water ad libitum. Parturition was
checked daily, and the day of birth was considered postnatal day P0. On
P2, all pups were briefly gathered, and 10 pups were assigned at random
to each dam. They experienced one of the following early-life rearing
conditions: (1) brief separation from the dam (augmented care, or “aug-
mented experience”), which took place daily from P2 to P8; or (2) un-
disturbed controls that remained in cages that were not touched between
P2 and P8. Rats were either killed on P9, between 8:00 A.M. and 12:00
P.M., or maintained under standard animal facility rearing conditions,
weaned on P21, and grown three to four per cage into adulthood. All
experiments were approved by the University Animal Care Committee
and conformed to National Institutes of Health (NIH) guidelines.
Augmentation ofmaternal care via brief daily separation and observation
of maternal care. Cages were brought into the laboratory daily at 8:30
A.M. The dam and the pups were placed into separate bedded cages
(pups were kept euthermic via a heating pad located underneath the
cage). After 15min, pupswere placed back into their home cage, followed
by the dam, and returned to the vivarium. Undisturbed litters remained
in the vivarium from P2 to P9. For all experimental groups, cage change
did not occur during this time. After pups and the dam were returned to
the vivarium, maternal behavior (including licking and grooming) was
observed using a protocol based on thework of Liu et al. (1997) as used by
Fenoglio et al. (2006). Maternal behavior was also determined in undis-
turbed litters. Each maternal observation session consisted of 10 epochs
of 3 min each. Within each epoch, the duration of licking and grooming
of pups was recorded during the first minutes. The total amount of time
spent licking and grooming was scored per session, added for all the
sessions, andmultiplied by three to provide the total amount ofmaternal
care during the 30 min session.
In situ hybridization for CRH mRNA. Rats were rapidly decapitated at
P9 (n  5 for control, n  6 for experience-augmented pups) and be-
tween P45 and P60 (n  4 per group), and the brains were quickly
dissected and frozen in dry ice. Brains were sectioned at 20 m using a
cryostat, collected onto gelatin-coated slides, and stored at80°C. In situ
hybridization (ISH) histochemistry was conducted as described previ-
ously using deoxy-oligonucleotide probes (Avishai-Eliner et al., 2001b).
The probe was labeled with 35S using routine terminal deoxynucleotide
transferasemethodology. Briefly, sectionswere brought to room temper-
ature, air dried, and fixed in fresh 4% buffered paraformaldehyde (PFA)
for 20 min, followed by dehydration and rehydration through graded
ethanols. Sections were exposed to 0.25% acetic anhydride and 0.1 M
triethanolamine, pH 8, for 8 min and dehydrated through graded eth-
anols. Prehybridization and hybridization steps were performed in a
humidified chamber at 42°C in a solution of 50% formamide, 5 SET
(750 mM NaCl, 150 mM Tris, 12.5 mM EDTA), 0.2% SDS, 5 Denhart’s
solution, 0.5 mg/ml salmon sperm DNA, 0.25 mg/ml yeast tRNA, 100
mM dithiothreitol, and 10% dextran sulfate. After a 1 h prehybridization,
sections were hybridized overnight with 0.25  106 cpm of labeled
probe. After hybridization, sections underwent serial washes at 42°C,
most stringently at 0.3 SSC for 30 min at room temperature. Sections
were then dehydrated through increasing ethanol concentrations, air
dried, and apposed to film (Kodak BioMax MR Film; Eastman Kodak)
for 5–10 d.
The ISH signal was analyzed on scanned, digitized paraventricular
nucleus of the hypothalamus (PVN) images of sections at coronal levels
corresponding at 3.8–3.5 mm anterior to bregma. The Image Tool soft-
ware program (University of Texas Health Science Center, San Antonio,
TX) was used (Fenoglio et al., 2006) after determining the linear range of
optical densities (ODs) using 14C standards. Values were only used if
they fell in the linear range and were corrected for background by sub-
tracting the OD of signal over the thalamus. The OD from two optimal
sections was averaged to generate an expression value for each PVN,
which is expressed in nanocuries per gram. These values were then used
to calculate group means SEM.
Immunocytochemistry studies. At P9 or at P45, rats were anesthetized
with sodium pentobarbital (100 mg/kg, i.p.) and perfused through the
ascending aorta with 0.9% saline solution, followed by freshly prepared,
cold 4% PFA in 0.1 M sodium phosphate buffer (PB), pH 7.4, cryopro-
tected in 15 and 30% sucrose/PB solution, and stored at 80°C. Brains
were sectioned at 30 m using a cryostat, and sections were collected as
four series with 90 m intervals between sections in tissue-culture wells
containing 0.1 M PB. Every fourth matched section was subjected to
immunocytochemistry (ICC). For each experiment, sections of
experience-augmented and control rat brains were processed concur-
rently in parallel wells.
For single-labeling CRH ICC, free-floating sections of experience-
augmented (n 5) and control (n 5) rats were subjected to standard
avidin–biotin complex (ABC) methods (Fenoglio et al., 2006). Briefly,
after several washes with 0.01 M PBS containing 0.3% Triton X-100, pH
7.4 (PBS-T), sections were treated for 30 min in 0.3% H2O2 in PBS,
followed by blockade of nonspecific sites with 1% bovine serum albumin
(BSA) in PBS for 30 min and incubation for 48 h at 4°C with anti-CRH
(1:40,000; gift from Dr. W. W. Vale, Salk Institute, La Jolla, CA) in PBS.
After three 5 min washes in PBS-T, sections were incubated in biotinyl-
ated rabbit anti-goat IgG (1:200; Vector Laboratories) in PBS containing
1% BSA for 2 h at room temperature. After washing in PBS-T (three
times for 5min), sections were incubated in ABC solution (1:100; Vector
Laboratories) for 2 h at room temperature. Sections were then rinsed
again in PBS (three times for 5min). The reaction product was visualized
by incubating sections for 8–10 min in 0.04% 3,3-diaminobenzidine
(DAB) containing 0.01% H2O2.
All counts were performed without knowledge of experimental group
(blindly). CRH-immunopositive cells were visualized using a Nikon
E400 microscope and counted in anatomically matched sections using
systematic sampling methods. Briefly, CRH-immunopositive cells were
counted in four sections that were 90 m apart per animal. We obviated
double counting by focusing throughout the 30 m section and includ-
ing a cell only at the level at which it had a clear complete nuclear profile.
Because the diameter of the CRH-positive cell nucleus was considerably
smaller than the thickness of each cryostat section, each cell was counted
once only. The PVN and central nucleus of the amygdala (ACe) were
sampled at coronal levels 3.8–3.5 mm anterior to bregma, and the bed
nucleus of the stria terminalis (BnST) was sampled at levels correspond-
ing to 5.0–4.7 mm anterior to bregma. The intensity of CRH immuno-
reactivity was analyzed on photomicrographs taken through a digital
camera (Spot Digital camera, RT color V3.0; Diagnostics Instruments)
with a standardized light source and standardized exposure. Analyses
were performed using ImageJ (version 1.41; NIH, Bethesda, MD). Den-
sities are expressed in OD units after correcting for background by sub-
tracting the density of the immunoreactive signal over the anterior
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commissure. Numbers of CRH-immunopositive neurons and CRH OD
from four sections were averaged. The numbers of cells per section and
OD per section were used to calculate group means SEM.
For double-labeling ICC of CRH and vGlut2 (the predominant vGlut
isoform in the hypothalamus) (Herzog et al., 2001), sections of
experience-augmented and control rats (n 3 per group) were washed
three times for 10min in 0.01 M PBS and treated with 1%Triton X-100 in
0.01 M PBS for 30 min. Sections were placed in 2% normal goat serum
and incubated for 48 h at 4°C in a mixture of rabbit anti-CRH serum
(1:10,000) and guinea pig anti-VGlut2 serum (1:10,000; AB5907; Milli-
pore). After three 10 min washes in 0.01 M PBS, sections were incubated
in a secondary antiserum mixture (1:400; goat anti-rabbit IgG 568 and
goat anti-guinea pig IgG Alexa Fluor 488; Invitrogen).
The number of vGlut2 boutons contacting PVN–CRH neurons was
assessed by confocal laser-scanningmicroscopic analysis (n 66 cells for
control, n 76 cells for experience-augmented rats). Images of the par-
vocellular division of the PVN (at coronal levels 3.8–3.5 mm anterior to
bregma) were collected using an LSM510 confocal scanning system
(Zeiss). Five 2-m-thick optical sections were collected along the z-axis
throughout the thickness of the whole neuron. Images were acquired
with an excitation wavelength of 488 nm (green) and 543 nm (red) with
a 40 oil objective using the minimum pinhole size. Images were im-
ported as TIFF files at the resolution of 1024  1024 pixels. vGlut2
boutons contacting PVN–CRH neuron were counted through the com-
plete z-axis in each optical section and averaged (vGlut2 boutons/optical
section/CRH cell). A vGlut2 bouton was considered to be apposed to the
CRHcell body onlywhen therewas no visible space between theCRHcell
membrane and the bouton. In addition, cell size was measured in the
central optical section for each CRH neuron using LSM Image browser
software (version 4.2.0.121; Zeiss). Analyzed cells were selected based on
the following criteria: (1) CRH immunopositive; (2) fully visible soma
within the Z-stack; and (3) a clearly identifiable nucleus. After all of the
quantitative analyses were completed, images used for illustration were
optimized for brightness and contrast using Adobe Photoshop 7.0.
Western blot. Samples consisted of micropunched PVN (Palkovits,
1973) or dissected thalamus from an individual rat. Rats were rapidly
decapitated at P9 (n 12 per group) and at P45 (n 5 per group), and
the brains were quickly dissected and frozen on powdered dry ice. The
PVN was punched out (21 gauge needle) from consecutive 150-m-
thick cryostat sections. Tissue was homogenized in 1.5 ml Eppendorf
tubes in ice-cold 0.32 M sucrose and 0.1 M Tris-HCl, pH 7.4, containing a
protease inhibitor mixture (Complete; Roche; diluted according to the
manufacturer’s instructions). Protein concentration was determined
(Bio-Rad), and equal amounts of proteinwere diluted in Laemmli buffer,
separated by SDS-PAGE, and visualized using the enhanced chemilumi-
nescence (ECL)-Plus kit (GE Healthcare) as described previously (Brewster
et al., 2005). Briefly, 2 g of protein extracts were separated on a 10%
SDS-PAGE and transferred to Hybond-P polyvinyl difluoride mem-
branes (GEHealthcare).Membranes were blockedwith 10%nonfatmilk
in 1 PBS overnight at 4°C and probed with guinea pig anti-vGlut2
(1:800,000; AB5907; Millipore), rabbit anti-vGat (1:150,000; generous
gift from Dr. R. Edwards, University of California San Francisco, San
Francisco, CA), or rabbit anti-NRSF (1:20,000; H-290-sc25398; Santa
Cruz Biotechnology) in each case combined with rabbit anti-actin (1:
60,000; Sigma). After washes in PBS-T (three times for 5 min), mem-
branes were incubated with secondary antibodies made in donkey,
conjugated to horseradish peroxidase (1:10,000) in 5% nonfat milk in
PBS for 1 h at room temperature. Membranes were washed in PBS-T
(three times for 5 min) and incubated with ECL-Plus. Immunoreactive
bands were visualized by apposing membranes to Hyperfilm ECL (GE
Healthcare). PVN and thalamic extracts of individual rats of different
groups were run concurrently on the same gel. Specificity of signal was
examined by excluding the primary antibodies in the presence of the
secondary antibodies. These treatments resulted in no immunoreactive
vGlut2, vGat, or NRSF bands.
Western blot data acquisition and analysis were accomplished bymea-
suring the OD of immunoreactive bands from the ECL films using Im-
ageTool. Several durations of exposure were performed to ascertain that
ODswere in a linear range. TheODof vGlut2, vGat, andNRSF bandswas
normalized to -actin of the same sample. Individual ODs were normal-
ized to the mean value of the control OD and used to generate mean
values per group SEM.
Electron microscopic immunostaining. P9 rats were anesthetized with
sodium pentobarbital (100 mg/kg, i.p.) and perfused through the as-
cending aorta with 0.9% saline solution, followed by freshly prepared,
cold 4% PFA; 15% picric acid; and 0.08% glutaraldehyde in 0.1 M PB, pH
7.4. Brains were removed and postfixed in 4% PFA overnight and stored
in 0.1 M PB. Brains were sectioned at 30musing a Vibratome (Lancer),
and sections were collected in multiwell plates containing 0.1 M PB. For
CRH ICC, free-floating sections of experience-augmented (n  5) and
control (n 5) rats were processed according to standard ABCmethods
with minor adaptations for the electron microscopic staining. Specifi-
cally, sections were treated for 30 min in 0.3% H2O2 in PBS. Sections
were incubated for 1 h in freezing solution (0.1 M PB, 25% sucrose, and
10% glycerol) followed by freeze/thaw in liquid nitrogen repeated three
times. Then sectionswerewashed several timeswith 0.01MPBS, followed
by incubation in 1%BSA in PBS for 30min to block nonspecific staining.
After a 10 min rinse in PBS, sections were incubated for 48 h at 4°C with
anti-CRH (1:40,000) in PBS containing 1% BSA and washed three times
in PBS-T for 5 min each. Subsequently, sections were incubated in bio-
tinylated rabbit anti-goat IgG (1:200; Vector Laboratories) in PBS for 2 h
at room temperature. After washing in PBS (three times for 5 min),
sections were incubated in ABC solution (1:100; Vector Laboratories) for
2 h at room temperature. Sections were then rinsed again in PBS (three
times for 5 min). The reaction product was visualized by incubating
sections for 8–10 min in 0.04% DAB containing 0.01% H2O2. Sections
were then osmicated (1% OsO4 in PB) for 30 min, dehydrated through
increasing ethanol concentrations (using 1% uranyl acetate in 70% eth-
anol for 30min), and flat embedded inDurcupan between liquid release-
coated slides and coverslips (Electron Microscopy Sciences) followed by
capsule embedding. Blocks were trimmed, and ribbons of serial ultrathin
sections were cut (Leica Ultracut E), collected on Formvar-coated single
slot grids, and examined under an FEI Biotwin electron microscope.
Semiquantitative analysis. The quantitative and qualitative analysis of
synapse number was performed in a blinded manner. To obtain a com-
plementary measure of an axosomatic synaptic number, unbiased for
possible changes in synaptic size, the dissector technique was used. On
consecutive 90-nm-thick sections, we determined the average projected
height of the synapses and used about 30% of this value as the distance
between the dissectors. On the basis of this calculation, the number of
axosomatic synapses was counted in two consecutive serial sections
about 270 nm apart (termed “reference” and “look-up” sections) of 10
CRH-immunolabeled perikarya profiles in each animal. Synapse charac-
terization was performed at a magnification of 20,000. Symmetric and
asymmetric synapses were counted on all selected neurons only if the
presynaptic and/or postsynaptic membrane specializations were seen
and synaptic vesicles were present in the presynaptic bouton. Synapses
with neither clearly symmetric nor asymmetric membrane specializa-
tions were excluded from the assessment. The plasma membranes of
selected cells were outlined on photomicrographs, and their length was
measured with the help of a cartographic wheel. Plasma membrane
length values measured in the individual animals were added, and the
total length was corrected to the magnification applied. Synaptic densi-
ties were evaluated according to the formulaNVQ/Vdis, whereNV is
the number per volume, Q is the number of synapses present in the
reference section that disappeared in the look-up section, and Vdis is the
dissector volume (volume of reference), the area of the perikarya profile
multiplied by the distance between the upper faces of the reference and
look-up sections (i.e., the data are expressed as numbers of synaptic
contacts per unit volume of perikaryon). Section thickness was deter-
mined using the Small’s minimal fold method. The synaptic counts were
expressed as numbers of synapses on a 100 mmembrane length unit.
Electrophysiology. Whole-cell recordings were made from presumed
CRH neurons from the parvocellular paraventricular hypothalamic nu-
cleus. Rats were rapidly decapitated at P9 (n 8 rats per group), and at
P30 (n  3 rats per group), brains were quickly dissected and 300 m
hypothalamic slices were cut using a vibratome. Hypothalamic slices
were maintained at 33°C and perfused with artificial CSF (ACSF). The
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bath solution (ACSF) consisted of (in mM) 124 NaCl, 3 KCl, 2 CaCl2, 2
MgCl2, 1.23 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4, with NaOH
and was continuously bubbled with 5% CO2 and 95% O2. The patch
pipettes were made of borosilicate glass (World Precision Instruments)
with a Sutter micropipette puller (PP-97). The tip resistance of the re-
cording pipettes was 4–6 M after filling with a pipette solution con-
taining 145 mM KMeSO4, 1 mM MgCl2, 10 mM HEPES, 1.1 mM EGTA, 2
mMMg-ATP, and 0.5mMNa2-GTP, pH 7.3, with KOH and 0.1% Lucifer
yellow (LY). After a gigaohm seal and a whole-cell access were achieved,
the series resistance was between 20 and 40 M and partially compen-
sated by the amplifier. Both input resistance and series resistance were
monitored throughout the experiments. Miniature EPSCs (mEPSCs)
andminiature IPSCs (mIPSCs)were recorded under voltage clamp in the
presence of tetrodotoxin (TTX) and bicuculline with a pipette solution
containing KMeSO4 (for mEPSCs) or TTX and CNQX plus AP-5 with a
pipette solution containing KCl (for mIPSCs) with a multiclamp 700A
amplifier (Molecular Devices). The use of KCl significantly increases the
conductance of GABAA receptors and makes recording mIPSCs easier.
PVN cells were held at60 mV. Detection of mEPSC andmIPSC events
were performed off-line with the software Axograph 4.9 (Molecular De-
vices). The frequency and amplitude of mEPSCs (or mIPSCs) were gen-
erated after detection ofmEPSC events, as described previously (Gao and
van den Pol, 2001). Putative CRH neurosecretory parvocellular PVN
neurons were identified on the basis of their visualized position within
the PVN and based on the shape of the neuron.
Immunocytochemical identification of CRH neurons. After recording
with electrodes containing LY in the pipette solution, slices were post-
fixed overnight in 4% PFA at 4°C overnight, washed in 0.1 M PB, embed-
ded in agar, and sliced with a vibratome to 50-m-thick sections. After
washes in PBS-T, sections were incubated with rabbit anti-CRH
(1:10,000) in 1% BSA in PBS-T for 48 h at 4°C. After three 5 min washes
in PBS-T, goat anti-rabbit antibody (Alexa Fluor 568; 1:400) in 1% BSA
in PBS-T was applied for 3 h to label CRH neurons. Sections were then
sealed on glass slides with Vectashield to avoid bleaching and examined
with a fluorescentmicroscope (Zeiss Axiophotmicroscope). The overlap
of LY images with Alexa Fluor 568 staining was taken as identification of
CRH neurons; however, leakage of cell contents including the LY in the
slices impeded positive identification of the recorded neurons. There-
fore, we considered for analysis only recorded neurons residing in the
CRH-rich, dorsomedial parvocellular field of the PVN.
Chromatin immunoprecipitation. Chromatin immunoprecipitation
(ChIP) assay was based on a fast ChIP protocol (Nelson et al., 2006).
Brains were dissected from P12 rats, and hippocampi were isolated, fro-
zen in tubes on dry ice, and stored at 80°C until use. All ChIP buffer
solutions contained protease inhibitor complex (Roche). Cross-linking
was achieved by adding 1ml of 1% formaldehyde in PBS, dicing the tissue
with scissors, and incubating at room temperature for 20 min. Samples
were spun 5 min at 800  g at 4°C, and the supernatant was discarded.
Pellets were washed twice with 1 ml of 0.125 M glycine in PBS and spun 5
min at 800  g, and the supernatant was discarded. Next, tissue was
homogenized in 1ml of hypotonic buffer (10mMKCl, 10mM Tris, pH 8,
and 1.5 mMMgCl2) using a Dounce homogenizer with an A pestle. Sam-
ples were then incubated on ice for 15 min, allowing the cells to swell,
followed by the addition of 100l of 10%NP-40 and spinning of samples
1 min at 16,000  g. The supernatant was discarded, and 360 l of
radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris, 150
mM NaCl, 1% NP-40, 0.1% SDS, 5 mM EDTA, and 1 mM EGTA) was
added to the remaining nuclear pellet. Samples were then sonicated for
10 min on a high setting (30 s on/30 s off) using a Bioruptor sonicator
(Diagenode). Samples were then spun 5 min at 16,000 g, and the top
350 l of the supernatant was added to 100 l of 50% protein G-agarose
bead slurry blocked with salmon sperm DNA (Millipore) and 1ml of
RIPA buffer. Samples were incubated on a rotator at 4°C for 1 h, spun at
3300 g for 1 min, and transferred to new tubes as ChIP input samples.
From ChIP input tubes, 425 l samples were aliquoted to new tubes for
incubation with 2.5 g of NRSF antibodies (H290; Santa Cruz Biotech-
nology) or IgG. Samples were incubated on a rotator at 4°C overnight
and spun at 16,000 g for 10 min, and the top 360l of the supernatant
was transferred to a tube containing 30 l of 50% protein G-agarose
beads. Samples were incubated on the rotator at 4°C for 1 h and spun at
3300 g for 1 min. The supernatant was discarded, and the beads were
washed five times by adding 1 ml of RIPA buffer, incubating on the
rotator at 4°C for 5 min, spinning at 3300 g, and aspirating the super-
natant. A total of 65l of 20%Chelex (Bio-Rad) inwater was added to 20
l aliquots of the original ChIP input samples and to each pellet. The
tubes were briefly mixed with a Vortex mixer and incubated in boiling
water for 10 min. The samples were allowed to cool and were spun at
16,000 g for 2 min. The top 35l of supernatant containing immuno-
precipitated or input DNA was transferred to new tubes for analysis.
PCR on recovered DNA was performed using primers directed at
the Crh gene (forward, AGTTTGGGGAAGACTTAGGAAGAG; reverse,
CTATCCGACAGACACAGACAAGAC) or the  actin gene (forward,
GACTACCTCATGAAGATCCTGACC; reverse, GAGACTACAACT-
TACCCAGGAAGG). Gotaq green (Promega) polymerase mix was used
with 10 M of each primer and 1–4 l of DNA template per 20 l
reaction. ChIP input DNA samples were used to adjust the amount of
DNA used in each PCR to equivalent levels. After 30 cycles of PCR,
products were run through gel electrophoresis along with samples of a
quantitative DNA ladder (Bioline Hyperladder I). Ethidium bromide
and UV light was used to visualize the DNA bands, and images were
captured. Image analysis was performed on blinded samples using Im-
ageJ software (NIH) to produce a standard curve from the quantitative
DNA ladder. Band intensities for the PCRproductswere quantified using
the standard curve.
Statistical considerations and analyses. All analyses were conducted
without the knowledge of treatment. The significance of differences be-
tween groups was set at 0.05. Differences in the maternal behavior of
control and experimental dams were analyzed using repeated-measures
ANOVA, in which treatment and time were included as fixed effects and
dam was included as a repeated (subject) effect, using SAS version 9.2
(SAS Institute). To correct for potential litter effect, the significance of dif-
ferences among groups were examined using amixed-model ANOVAwith
treatment as a fixed effect and the dam as a random effect, using SAS.
Results
Brief daily separation of the pups from their mother increases
sensory stimulation of pups by the dam
Brief (15 min) separation of pups from their mother (“han-
dling”) has been shown to enhance maternal nurturing behav-
iors, such as licking and grooming, toward the pups (Brown et al.,
1977; Liu et al., 1997; Fenoglio et al., 2006). In addition, our
Figure 1. Sensory stimulation of pups by the dam is enhanced daily after brief separation of
pups from their mother. Maternal stimulation of the pups, specifically licking and grooming,
was observed and quantified daily fromP2 to P8 during the 30min after the return of separated
pups and dams to home cages. The duration of these sensory stimulations of the pups was
twofold higher in litters that were separated comparedwith control dams on each day (n 16
dams per group; repeated-measures ANOVA; F(1,31) 39.94; p 0.0001).
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previous work found that bursts or a vig-
orous bout of sensory input to the pups
was generated during the 30 min after the
return of the pups to the dam. These find-
ings were confirmed in the current exper-
iments: the return of the pups to the home
cage elicited a barrage of maternally de-
rived sensory stimulation. Specifically,
maternal licking and grooming was in-
creased twofold during the first 30 min
after the pups’ return (controls, 304.2 
14.4 s vs separated dams, 614.4  28.2 s;
F(1,31)  39.94; p  0.0001) These bursts
of sensory stimulation of the pups oc-
curred daily throughout the week of the
experiment (Fig. 1).
CRH levels in the hypothalamic
PVN are reduced by augmented
early-life experience
Hypothalamic parvocellular CRH expres-
sion at the mRNA and protein levels were
examined on P9 in rats experiencing the
augmented maternal care from P2 to P8,
compared with controls that were raised
without disturbance. CRH mRNA levels
in the PVN of separated rats (experience
augmented) were significantly lower than
those of control pups (61  6.3%; p 
0.05) (Fig. 2A), and this was observed al-
ready by P9, consistent with previous
findings (Avishai-Eliner et al., 2001a;
Fenoglio et al., 2006). These changes in
mRNA expression were translated into
changes in protein expression. As shown
in Figure 2, B and C, the intensity of CRH
immunoreactivity over the PVN was
reduced in the experience-augmented
group (experience augmented, 0.13 
0.04 OD units/section vs control animals,
0.16  0.05 OD units/section; p  0.05),
whereas the total number of CRH-ex-
pressing neurons was unchanged (control,
71  5 cells/section; experience-aug-
mented rats, 68 5 cells/section). The ef-
fects of augmented early-life experience
were specific to the CRH-expressing neu-
ronal population in the hypothalamic
PVN: neither the overall OD nor the total
number of CRH-immunopositive cells
was altered in the ACe or the BnST. Thus,
CRH immunoreactivity in ACe in P9 ex-
perience-augmented and control rats av-
eraged 0.06  0.02 and 0.06  0.02 OD
units/section, respectively, and thenumbers
of neurons expressing CRH in ACe aver-
aged121and131cells/section, respec-
tively. The BnST of control rats had an
averageof 0.050.02ODunits/sectionand
48  2 CRH-expressing neurons/section
compared with 0.05  0.02 OD units/sec-
tionand40.05cells/section inBnST from
experience-augmented rats.
Figure2. Augmentedearly-lifeexperience leads toearlyonsetandpersistent reduction inCRHexpression inparvocellularPVNatboth
mRNA and protein levels. A, Representative bright-field photomicrographs of coronal sections at the level of the PVN from control and
experience-augmented rats. The sections were subjected to ISH for CRH mRNA. CRH mRNA expression was reduced by 52% in P9
experience-augmented rats comparedwith undisturbed controls.B, Bright-field photomicrographs, taken under similar viewing param-
eters, showing CRH immunohistochemistry in PVN of control and experience-augmented rats. C, Quantitative analysis of the numbers of
CRH-ir neurons and intensity of the immunoreactivity. The changes observed for mRNA expression were translated to protein levels as
apparent fromthe20%reduction in the intensity of CRHexpression in experience-augmented rats.D, Representative autoradiographs
after CRHmRNA ISH of CRHmRNA signal in adult control and experience-augmented rat PVN. CRH expression in experience-augmented
adult rats was 50% lower comparedwith controls, indicating that repressed CRH expression, found on P9, was long-lasting. E, F, Bright-
fieldphotomicrographsandquantitativeanalysisofCRHimmunohistochemistry inadultPVN.TheenduringsuppressionofCRHexpression
observed at the mRNA level was translated to the protein level as evident from the21% reduction in CRH-ir cells in the experience-
augmented rats. 3rd, Third ventricle. Scale bars:A,D, 500m;B, E, 200m.Data are represented asmean SEM. *p 0.05.
Figure 3. Levels of the marker for excitatory synapses vGlut2 are reduced in PVN from immature rats with augmented early-life
experiencecomparedwithcontrols.A,C, RepresentativeWesternblotsandquantitativeanalysisofvGlut2proteinexpression in thePVNof
P9 controls and rats with augmented early-life experience. vGlut2 levels were reduced by 40% in augmented-experience rats compared
withcontrols.B,C,WesternblotsandquantificationofvGlut2 in thalamic tissueofP9controlandaugmentedearly-lifeexperiencecohorts.
No differences in thalamic vGlut2 levels were seen, indicating that the reduction in vGlut2 levels was specific to the PVN.D, Western blot
vGat levels in the PVN of P9 control rats compared with cohorts with augmented early-life experience. vGat levels in the PVN were not
affected by this early-life experience. All groups were run concurrently on the same gels, and the OD of vGlut2- and vGat-ir bands was
normalized to that of actin for each lane. Data are represented asmean SEM. *p 0.05.
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The longevityof the alteredCRHexpres-
sionwas examined in rats experiencing aug-
mented maternal care from P2 to P8 and
killed as young adults (at P45–P60). At the
mRNA level, PVN CRH expression re-
mained lower inexperience-augmented rats
(50 4%of control values; p 0.001) (Fig.
2D), consistent with our previous findings
(Avishai-Eliner et al., 2001a; Fenoglio et al.,
2005).This reductionwas evident also at the
protein level (Fig. 2E,F). The number of
CRH-expressingneuronswas lower (584
neurons/section) in adult experience-aug-
mented rats compared with the control co-
hort (75  4 neurons/section; p  0.05),
whereas the intensity of CRH immunoreac-
tivity was not altered (control, 0.06 0.02
OD units/section vs experience-augmented
rats, 0.07 0.02 OD units/section). Similar
to P9, this reduction was specific to the
PVN, because no differences in the number
of CRH-expressing neurons or intensity of
the immunoreactive signal were detected in
the ACe (control, 0.10  0.05 OD units/
section and 47  10 cells/section; experi-
ence-augmentedrats, 0.120.05ODunits/
section and 44 4 cells/section) or in the
BnST (control, 0.13  0.05 OD units/sec-
tion and 17  6 cells/section; experience-
augmented rats, 0.13  0.07 OD units/
section and 12  2 cells/section).
Interestingly, the numbers of CRH cells in
the ACe and BnST differed in both groups
between P9 and P45, with inverse trends in
cell numbers with age in the two structures.
We can only speculate that this might be a
result of developmental changes.
Repressed CRH expression in PVN
neurons of experience-augmented rats
is associated with reduction in
excitatory synaptic input
The reduction in CRH expression in PVN
of experience-augmented rats starts early
(P9), endures for life, and is associatedwith
lifelong reduction in hormone release in re-
sponse to stress, potentially indicating al-
tered sensitivity of the CRH neuron to
excitation by stress. Therefore, we tested the
possibility that augmented early-life experi-
ence leads to a reduced excitatory drive (or
increased inhibition) onto CRH-expressing neurons.
We first examined whether the levels of the vesicular trans-
porters of glutamate (vGlut2) and GABA (vGat), which are
markers of presynaptic elements of glutamatergic and GABAer-
gic synapses, respectively, were influenced by augmented mater-
nal care. In punched PVN tissue, vGlut2 was detected as a single
major band (60 kDa) (Fremeau et al., 2004). Protein levels of
vGlut2 (normalized per actin and per controls) were significantly
lower in experience-augmented comparedwith control rats: 60.5
11.4 versus 101.7  12.5 OD units, respectively ( p  0.01) (Fig.
3A,C). The changes in vGlut2 were selective to the PVN and were
not observed in the thalamus (controls, 100.0 32.4 vs experience
augmented, 92.9 36.9) (Fig. 3B,C). In contrast to vGlut2, protein
levels of vGat were unaffected by early-life experience (49.1 6.6 vs
59.1 8.7 OD units in experience-augmented and control groups)
(Fig. 3D).
The numbers of vGlut2 boutons contacting CRH-
immunoreactive (ir) neurons in the parvocellular PVN are
lower in rats experiencing augmented maternal care early in
life compared with controls
To examine whether the reduction in vGlut2 protein levels in
experience-augmented rat PVN represented a reduced number
of glutamatergic, excitatory synapses onto CRH neurons, we
Figure 4. Fewer excitatory (vGlut2-positive) boutons contact CRH-ir neurons in parvocellular PVN of immature rats with aug-
mentedmaternal experience compared with the controls. A, B, Merged confocal microscope images of sections at the level of the
PVNdouble labeled for vGlut2 (green) andCRH (red) in control andaugmentedearly-life experienceP9 rats. vGlut2-ir boutonswere
frequently juxtaposed onto somata and proximal dendrites of CRH-ir neurons. The number of vGlut2 boutons contacting the soma
of CRH-ir neurons (arrow) was reduced by 36% in augmented early-life experience rats compared with controls, as shown in the
high-magnification confocal images. C, D, CRH immunostaining (left), vGlut2-immunopositive boutons (middle), and merged
image (right). Cell sizes, assessed by measurement of the circumference of the soma of PVN CRH-expressing cells, were not
different between experience-augmented and control rats. Scale bars, 10m.
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identified excitatory glutamatergic boutons on CRH neurons us-
ing double immunolabeling for vGlut2 and CRH. In virtual con-
focal sections (2 m), vGlut2-ir axon varicosities were frequently
juxtaposedonto somata andproximaldendrites ofCRH-irneurons.
The CRH-expressing neurons were located in the medial parvocel-
lular subdivision of the PVN (Sawchenko and Swanson, 1985), and
their total numbers per section did not differ among the two exper-
imental groups (see above). The numbers of vGlut2 boutons on
individual CRH-ir cells were lower in experience-augmented rats
(5.4 0.9 vGlut2 boutons/optical section/cell) comparedwith con-
trols (8.4  0.9; p  0.05) (Fig. 4). The size of CRH neurons, as
assessed by measuring cell surface was not affected by the early-life
experience (perimeter: controls, 32.87 0.48m,n 37 cells from
three rats; experience-augmented pups, 33.36  0.51 m, n  41
cells from three rats; p 0.3).
The number of asymmetric synapses on PVN–CRH-
immunolabeled cells is reduced in rats that experienced
enhancedmaternal care early in life versus control groups
The reduced number of vGlut2-positive glutamatergic synapses
abutting CRH-expressing cells could be a result of either a dimin-
ished number of synapses or a reduced synapse size. To distinguish
between these two possibilities, we examined the density and struc-
tural identity of synapses ontoCRHcells using electronmicroscopy.
After immunolabeling for CRH, symmetric (inhibitory) and asym-
metric (excitatory) synapses onto CRH
neurons in the parvocellular PVN were ex-
aminedusing stereological principles. Total
synaptic density was lower in experi-
ence-augmented rats compared with con-
trol cohorts (18.9  6.2 vs 34.8  5.2
synapses/100msomaticmembrane; p
0.05) (Fig. 5). Additional analysis revealed
that this reduction was attributable pri-
marily to a drastically decreased density of
asymmetric excitatory synapses (from
11.6  3.7 to 3.4  2.2 synapses/100 m
somatic membrane; p  0.05) (Fig. 5). In
contrast to this 70% reduction in asym-
metric synapses, the number of symmetric
inhibitory synapses were not influenced
by early-life experience (experience-aug-
mented rats, 15.5 5.2 synapses/100 m
somatic membrane vs undisturbed con-
trols, 20.92.3 synapses/100m somatic
membrane) (Fig. 5).
The frequency of mEPSC events is
reduced in parvocellular-presumed
CRH neurons of augmented early-life
experience rats versus undisturbed
controls
The data above indicated that CRH-ex-
pressing neurons in the PVNof experience-
augmented rats were contacted by fewer
asymmetric, vGlut2-positive, excitatory
synapses. However, whether these struc-
tural changes influenced functional excita-
tory input impinging on these CRH
neuronswas unclear. Therefore, afferent in-
puts to presumed CRH neurons were mea-
sured using whole patch-clamp recordings
in acute hypothalamic slices from experi-
ence-augmented and control P9 rats. Cells from the CRH-rich dor-
sal parvocellular regionof thePVN(Fig. 6E)wereheldat60mVin
the whole-cell voltage-clamp configuration, in the presence of TTX
toblockall actionpotential-drivenPSCs.This enabledus toexamine
the frequency ofmEPSCs/mIPSCs that arise from spontaneous ves-
icle fusionandtypically reflect thenumberof transmitter release sites
(or the probability of release) (Regehr et al., 2001). Analysis revealed
that augmented early-life experience drastically reduced the fre-
quency ofmEPSCs [17.8 2.8 perminute (n 17) comparedwith
that in controls (44.2  9.4 per minute; n  15); p  0.01] (Fig.
6A,B), consistent with reduced numbers of presynaptic terminals
(or reduced probability of release).Whereas this reduced frequency
of mPSC events is indicative of presynaptic changes, the amplitude
of these currents is an indication of postsynaptic changes (e.g., re-
ceptor number, function, or both) (Regehr et al., 2001). mEPSC
amplitudewasmodestly increased in the experience-augmented rats
(12.4  0.7 pA; n  15) when compared with the control pups
(10.5  0.6 pA; n  14; p  0.05) (Fig. 6B). In contrast to the
changes in excitatory synapses, the frequency of mIPSCs did not
differ between groups (control, 47.5 13.6 per minute, n 15 vs
experience-augmented rats, 52.8  7.4 per minute, n  16) (Fig.
6C,D), whereas the amplitude increasedmodestly (30.7 2.3 pA,
n 15 vs47.8 6.8 pA,n 16) (Fig. 6D). Thus, the electrophys-
iological data supported the results obtained with quantitative bio-
chemical methods and confocal and electronmicroscopy.
Figure 5. Augmented early-life experience induces a lower number of asymmetrical putative excitatory synapses onto CRH
neurons. A, Left, High-magnification electron micrographs showing asymmetric (a; excitatory) and symmetric (s; inhibitory)
synaptic contacts between parvocellular CRH-immunopositive soma and unidentified axon terminals (arrows). Right, Examples of
synaptic contacts between CRHneurons and unidentified axon terminals (asterisks) of experience-augmented and control P9 rats.
B, Quantification of the total asymmetric and symmetric synapse density revealing 50% reduction in the total number of synapses
attributable to a 70% reduction in number of asymmetric synapses onto CRH neurons of augmented early-life experience rats.
Scale bars, 1m. Data are represented as mean SEM. *p 0.05.
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Reduced excitatory input is not
required for the maintenance of
repressed CRH expression in
hypothalamic neurons
CRH expression is repressed for life by
augmented early-life experience (Fig. 2).
The data above raised the possibility that
this repression was both initiated and
maintained by reduction in excitatory
input. Alternatively, repression of CRH
expression after augmented early-life ex-
perience might become autonomous, so
that altered innervation of the CRH neu-
ron was not required for the maintenance
of this effect. To address this question,
we examined excitatory and inhibitory
synaptic input onto hypothalamic CRH-
expressing neurons in older rats (P30–
P45). Examining the levels of vGlut2, we
found that by P45, protein levels of vGlut2
were no longer significantly lower than
those of the control rats [145.9 19.91 vs
112.8  47.86 OD units (normalized per
actin); p 0.05], consistent with normal-
ization of excitatory synapse input onto
CRH neurons of the former. In accor-
dance with this notion, the frequency of
mEPSCs and mIPSCs of presumed CRH
neurons in the PVN in experience-aug-
mented and undisturbed control P30
rats were no longer different (frequency
of mEPSC: control, 193  31 per
minute, n  15 vs experience-aug-
mented rats, 293  48 per minute, n 
20; frequency of mIPSC: control, 276 
105 per minute, n  6 vs experience-aug-
mented rats, 414  83 per minute, n  6;
p  0.05 for all comparisons). Together,
these data indicate that whereas diminished
excitatory input, resulting from reduced
numbers of excitatory synapses onto
CRH neurons of experience-augmented
rats, might be involved in initiating the
molecular machinery that represses CRH
gene expression in these cells, reduced ex-
citation was not necessary to maintain the lifelong repression of
the Crh gene.
Augmented early-life experience increases the levels of the
NRSF, and this enhancement is persistent
If experience-induced “rewiring” ofCRH-expressing neurons is not
required formaintaining the repression of theCrh gene, whatmight
the responsiblemolecularmechanisms for this persistent repression
be? To address this question, we evaluated the role of NRSF in regu-
lating theCrh gene by testing the ability of NRSF to bind to theCrh
geneandbymeasuring the effectsof augmentedearly-life experience
on levels ofNRSF inhypothalamicneurons.UsingChIP followedby
quantitative PCR,we found that amount of “Crh gene”DNAampli-
fiedbyPCRfromchromatin immunoprecipitatedwithantiserumto
NRSF was 39.2 4.7 ng, indicating binding of the repressor to the
regulatory region of the gene (Fig. 7A,B). The amount of Crh gene
DNA immunoprecipitated with nonimmune IgG and amplified by
PCR were undetectable under the ChIP conditions we used, as was
the amount of amplified PCR product from the anti-NRSF immu-
noprecipitatedDNAof the intronic region of actin, a gene devoid of
NRSE sites (Fig. 7A,B). Quantifying NRSF levels in punched PVN
tissue by Western blot analysis showed that NRSF migrated as a
singlemajor band (160 kDa). Protein levels of NRSF (normalized
peractin),onP9,weredramaticallyhigher inexperience-augmented
compared with control rats (147.6 23.6 vs 28.0 7.5 ODNRSF/
actin, respectively; p  0.05) (Fig. 7C,E). The experience-induced
upregulation of NRSF persisted long term. NRSF levels were still
strikingly higher in young-adult experience-augmented rats com-
pared with controls (655.5 332.9 vs 41.6 10.8 ODNRSF/actin;
p 0.05) (Fig. 7D,E). This augmentation of NRSF expression was
selective to thePVN,becausenodifference inNRSF levelswas found
in the thalamus (control, 199.8 47.1ODNRSF/actin; experience-
augmented rats, 195.2 46.9 ODNRSF/actin) (Fig. 7F). These re-
sults indicate that upregulation of NRSF levels likely contributes to
both initiationandpersistenceof the repressedCRHexpressionafter
augmented early-life experience.
Figure 6. The frequency ofmEPSC onto parvocellular CRH neurons is diminished in slices from augmented early-life experience
rats. A, Raw traces of recorded mEPSCs from control and augmented early-life experience P9 rats are presented. mEPSCs were
recorded in the presence of TTX (1M) and bicuculline (30M). B, Quantification representing mEPSC frequency and amplitude
from parvocellular-presumed CRH neurons. The frequency of mEPSC was 60% lower in neurons recorded from experience-
augmented rats compared with controls, consistent with reduced numbers of presynaptic terminals (or reduced probability of
release), accompanied by a mild increase in the amplitude of mEPSC indicative of minor postsynaptic changes. C, Raw traces of
recorded mIPSCs of parvocellular neuron of control and augmented early-life experience P9 rats. mIPSCs were recorded in the
presence of TTX (1M), CNQX (10M), and AP-5 (50M). D, Quantification representing mIPSC frequency and amplitude from
parvocellular-presumed CRH neurons. The frequency of mIPSC was not affected by the augmented early-life experience, whereas
amplitude ofmIPSCwas increased, indicative of postsynaptic changes.E, To identify the recordedneurons, theywere filledwith LY
at the timeof recordingandprocessed for CRH immunostaining. Becauseof leakageof cell contents and the LY in recordedneurons,
only a minority were dually labeled. Therefore, all recorded neurons considered for analysis came from the CRH-rich, dorsomedial
parvocellular PVN field as shown. Scale bar, 200m. Data are represented as mean SEM. *p 0.05. 3rd, Third ventricle.
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Discussion
The studies described here demonstrate that after augmented
early-life experience, the following occur:(1) expression of CRH
mRNA and protein in hypothalamic PVN neurons is de-
pressed, and (2) this depression is maintained to adulthood;
(3) functional glutamatergic innervation of CRH neurons in the
hypothalamus is markedly reduced, and (4) this experience-
induced reduction in excitatory innervation resolves by adult-
hood, indicating that the diminished excitatory input to the CRH
neuron is not required for the maintenance of the “repro-
grammed” expression levels of this gene; (5) augmented early-life
experience induces a marked increase in levels of NRSF, a tran-
scription factor negatively regulating Crh gene expression, and
this repressor binds directly to the regulatory region of the gene;
and (6) increased NRSF levels persist to
adulthood. Together, these results support
the idea that augmented early-life experi-
ence reduces excitatory input onto CRH-
expressing neurons. This reduced
excitation is associated with, and perhaps
initiates, a cascade of molecular events, in-
cluding upregulation of NRSF, which may
function to repress CRH expression.
Whereas excitation to theCRHneuronnor-
malizes with age, augmented NRSF levels
persist, potentially contributing to mainte-




Our data indicate that the input organiza-
tion of neurons in the developing hypothal-
amus is not hardwired but, rather, may be
influenced by early-life experience. Com-
bining molecular, morphological, ultra-
structural, and functional approaches, we
found that the number of excitatory,
vGlut2-ir boutons contactingCRHneurons
was diminished in experience-augmented
rats. This was associated with reduced
vGlut2 levels in the PVN and reduced fre-
quencyofmEPSCs, andall theseparameters
remained unchanged in inhibitory syn-
apses. The decreased frequency of mEPSCs
could be interpreted either as reduced pre-
synaptic excitatory elements or as reduced
release probability (Regehr et al., 2001);
however, the reduction in asymmetric syn-
apses onto CRH neurons, observed using
electron microscopy, supports the former
possibility (the minor but significant
changes in the amplitude of themPSCs sug-
gest postsynaptic changes thatwill need fur-
ther investigation). Similarly, reduced total
vGlut2 levels might be a result of reduced
synapse size rather than synapse number,
but the confocal and electron microscopy
studies clarified that the number of excita-
tory synapses onto identified CRH neurons
was attenuated after augmented early-life
experience. Together, these data provide ev-
idence for significant reduction inexcitatory
input onto CRH-expressing neurons of experience-augmented rats
(i.e., a rewiring of these neurons).
CRH neurons in the PVN integrate excitatory and inhibitory
drives fromanumber of sources. Both stimulatory and inhibitory
afferents from limbic and cortical areas are known to coordinate
CRHexpression and release (Sawchenko and Swanson, 1983), yet
there is little direct innervation of CRH neurons from these re-
gions (Herman et al., 2004). Instead, axons originating in hip-
pocampus, septum, amygdala, and prefrontal cortex contact local
(peri-PVN) or remote (BnST, preoptic area) relay GABAergic or
glutamatergic neurons (Tribollet andDreifuss, 1981;Herman et al.,
2004). Monosynaptic GABAergic inputs onto CRH neurons
originate in regions surrounding the PVN and the BnST and
Figure 7. NRSF binds specifically to the Crh gene, and its levels are dramatically increased by augmented early-life environ-
ment. A, Schematic view of the chromatin of the Crh gene. The regulatory region of the Crh gene contains an intronic NRSE, and
NRSF acts as a transcriptional repressor by binding to this element, recruiting cofactors and inducing epigenetic modification of
gene expression.B, Top, Amplified Crh intronDNA immunoprecipitatedwith anti-NRSF, yielding40 ng of DNA. This is compared
with undetectable DNA products immunoprecipitatedwith nonimmune IgG. Bottom, As an additional control for themethod, the
amounts of amplified Actin intron DNA (a gene devoid of an NRSE) that immunoprecipitates with anti-NRSF or with nonimmune
IgG are nil. These results indicate that NRSF specifically binds to the cognate sequence (NRSE), which is located within the Crh
intron. Ab, Antibody. C, E, Representative Western blots and quantitative analyses of NRSF protein expression in the PVN of P9
controls and augmented-experience rats. In concurrently run samples from both groups, NRSF levels were strikingly (5-fold)
increased in augmented-experience rats compared with controls. D, E, Western blots and quantitative analysis of NRSF protein
expression in the PVN of P45 controls and augmented-experience rats. The increase in NRSF levels observed on P9was persistent,
as evident from the 12-fold increase in NRSF levels on P45. F, NRSF levels were not altered by the augmented experience in the
thalamus, indicating that the effect of augmented early-life experience on NRSF expression was specific to the PVN. Data are
represented as mean SEM. *p 0.05.
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maintain a strong inhibitory tone over CRH neurons (Roland
and Sawchenko, 1993; Cullinan et al., 1996). Suppression of this
tonic GABAergic inhibition enables secretion of CRH in re-
sponse to glutamatergic activation (Cole and Sawchenko,
2002; Bartanusz et al., 2004), and functional changes in GABAer-
gic synapses abutting CRH neurons have been described in re-
sponse to physiological challenges (Miklos and Kovacs, 2002;
Verkuyl et al., 2004; Ziegler et al., 2005). Glutamatergic inputs
ontoCRH cells in PVNoriginate fromother hypothalamic nuclei
and fromBnST and amygdala (Aubry et al., 1996; Kiss et al., 1996;
Di et al., 2003; Herman et al., 2004; Wittmann et al., 2005). In-
deed, our previous work suggests that augmented early-life expe-
rience may reduce such excitatory input by activating a powerful
inhibitory signal to amygdala or BnST from the thalamic para-
ventricular nucleus (Bhatnagar and Dallman, 1998; Fenoglio et
al., 2006). The ability of glutamate and GABA to trigger direct
synaptic actions in presumed CRH neurons (Boudaba et al.,
1996, 1997) and the fact that excitation of these neurons provokes
rapid transcription of the Crh gene (Cole and Sawchenko, 2002;
Foradori et al., 2007), whereas elevating brain GABA levels re-
presses CRH expression (Tran et al., 1999; Cole and Sawchenko,
2002), support the idea that the reduced balance of excitation/
inhibition found here after early-life experience leads to suppres-
sion of CRH expression.
Early-life experience reprograms expression of
stress-related molecules
The consequences of early-life experience (i.e., a phenotype of
reduced stress responsiveness) (Plotsky and Meaney, 1993;
Avishai-Eliner et al., 2001a) and improved learning and memory
(Liu et al., 2000; Fenoglio et al., 2005) is associated with lifelong
increased expression of GR in hippocampus and reduced expres-
sion of CRH in PVN neurons (Plotsky and Meaney, 1993; Liu et
al., 1997; Fenoglio et al., 2005; Plotsky et al., 2005). We have
found previously that suppression of CRH mRNA commenced
already on P9 and that reduction in CRH–CRH receptor signal-
ing sufficed to endow immature rats with this phenotype (Feno-
glio et al., 2005). Therefore, we focused here on the mechanisms
by which augmented early-life experience regulated CRH expres-
sion, reprogramming this expression at lower levels. As men-
tioned above, we found that early-life experience reduced
excitation to CRH-expressing neurons and increased expression
of the transcriptional repressor NRSF. However, although the
experience-induced repression of CRH expression persisted, the
innervation of theCRHneurons normalized by adulthood. These
findings suggest that reduced excitation might contribute to the
initiation of the reprogramming of CRH expression levels but
was not required for its maintenance. Rather, the cellular pro-
grams repressing expression of the Crh gene have become auton-
omous of the reduced excitatory input.
What might these cellular mechanisms be? The levels of the
transcriptional repressor NRSF were dramatically (5- to 12-fold)
elevated in PVNof experience-augmented rats, and this elevation
persisted in parallel to repressed CRH expression. NRSF, origi-
nally thought to silence neuronal genes in non-neural cells, is
now known to be involved in neuronal plasticity (Palm et al.,
1998). NRSF binds to a 21 bp sequence (NRSE), and this se-
quence is found within the regulatory region (intron) of the Crh
gene (Seth andMajzoub, 2001).Our data are the first to show that
NRSF binds specifically to thisNRSE in vivo, in the hypothalamus
of the developing rat. This binding should promote recruitment
of cofactors contributing to epigenetic chromatin modification
(Zheng et al., 2009) and, if increased after augmented maternal
care, should result in repression of transcription of the Crh gene.
The involvement of epigenetic mechanisms in the programming
of the hypothalamic pituitary adrenal axis by early-life maternal
care has been demonstrated at the level of the promoter region of
GR (Weaver et al., 2005, 2006, 2007). The enduring enhancement
of hypothalamicNRSF levels, combinedwith the specific binding
of this repressor to the Crh gene are consistent with effects of this
repressor on transcription of the Crh gene throughout life.
The relationship of reduced excitation andNRSF expression is
intriguing. It has been shown that neuronal activity can influence
NRSF expression; for example, abnormally increased synchro-
nized excitation (seizures) augments NRSF expression in
hippocampus (Palm et al., 1998; McClelland et al., 2008). In ad-
dition, and germane to the current study, the levels of NRSF
diminish rapidly during the developmental period discussed here
(Palm et al., 1998).Whereas the regulation of this developmental
decline of NRSF is not fully understood, it is tempting to specu-
late that age-dependent increase in synaptic input might be re-
sponsible for this reduction. If so, then the decreased excitatory
synaptic input onto the hypothalamic CRH cell, provoked by
augmentedmaternal care, should result in increasedNRSF levels,
as found here.
In summary, early-life experience leads to transient rewiring
of hypothalamic neurons and reprogramming of Crh gene ex-
pression at suppressed levels. These result in a lifelong phenotype
of reduced stress responsiveness as well as improved cognitive
function. Therefore, understanding the basis of this experience-
related plasticity is profoundly important to human health and
disease and should provide the foundation of future therapeutic
interventions.
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